BDBM224323 3-{6-(5-chloropyridin-3-yl)-7-[1- (trans-4-methylcyclohexyl)ethyl]-8- [(2s)-2-(trifluoromethyl)pyrrolidin- 1-yl]-7h-purin-2-yl}-1,2,4- oxadiazol-5(4h)-one (mixture of diastereomers)::US9540377, 18.49

SMILES: CC([C@H]1CC[C@H](C)CC1)n1c(nc2nc(nc(-c3cncc(Cl)c3)c12)-c1noc(=O)[nH]1)N1CCC[C@H]1C(F)(F)F

InChI Key:

Data: 1 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 224323   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
p53-binding protein Mdm2 (Homo sapiens (Human))	BDBM224323 (3-{6-(5-chloropyridin-3-yl)-7-[1- (trans-4-methylc...) Show SMILES CC([C@H]1CC[C@H](C)CC1)n1c(nc2nc(nc(-c3cncc(Cl)c3)c12)-c1noc(=O)[nH]1)N1CCC[C@H]1C(F)(F)F |r,wU:5.5,wD:2.1,35.41,(.82,-2.85,;1.91,-1.76,;3.4,-2.16,;3.8,-3.65,;5.29,-4.05,;6.37,-2.96,;7.86,-3.36,;5.98,-1.47,;4.49,-1.07,;1.51,-.28,;2.42,.97,;1.51,2.22,;.05,1.74,;-1.28,2.51,;-2.62,1.74,;-2.62,.2,;-1.28,-.57,;-1.28,-2.11,;.05,-2.88,;.05,-4.42,;-1.28,-5.19,;-2.62,-4.42,;-3.95,-5.19,;-2.62,-2.88,;.05,.2,;-3.95,2.51,;-3.95,4.05,;-5.42,4.53,;-6.32,3.28,;-7.86,3.28,;-5.42,2.03,;3.96,.97,;4.86,-.28,;6.33,.2,;6.33,1.74,;4.86,2.22,;4.47,3.7,;5.55,4.79,;4.07,5.19,;2.98,4.1,)| Show InChI	PDB GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.670	n/a	n/a	n/a	n/a	n/a	25
Merck Sharp & Dohme Corp. US Patent					Assay Description An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...				US Patent US9540377 (2017) BindingDB Entry DOI: 10.7270/Q2RF5X1F
					More data for this Ligand-Target Pair